Evocalcet improved the PTH–calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism
Journal of Bone and Mineral Metabolism · 2026
DOI: 10.1007/s00774-026-01699-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2026. Verfasst von Yasuo Imanishi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka…. Hauptthemen laut MEDLINE: Cell Proliferation, Parathyroid Hormone, Parathyroid Glands, Calcium. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Evocalcet is an allosteric modulator of the calcium-sensing receptor (CaSR) that effectively suppresses parathyroid hormone (PTH) secretion in both primary and secondary hyperparathyroidism. However, its effects on the PTH-calcium setpoint and parathyroid cell proliferation remain unclear.
Methods
We investigated these effects using the PC mouse model of primary hyperparathyroidism, which is characterized by parathyroid-targeted cyclin D1 overexpression . Evocalcet was administered orally at a dose of 0.025 mg/g diet. The PTH-calcium setpoint was evaluated, and the antiproliferative effect of evocalcet on parathyroid cells was assessed using 5-bromo-2′-deoxyuridine (BrdU) incorporation assays. The effects of evocalcet were compared with those of cinacalcet. Expression levels of the vitamin D receptor (VDR) and CaSR in parathyroid glands were also examined.
Results
Evocalcet significantly reduced the PTH-calcium setpoint in PC mice, restoring it to levels comparable to those observed in wild-type controls. Evocalcet treatment markedly decreased the proportion of BrdU-positive parathyroid cells, indicating suppression of parathyroid cell proliferation. This antiproliferative effect was comparable to that observed with cinacalcet. Neither evocalcet nor cinacalcet altered VDR or CaSR expression in the parathyroid glands.
Conclusions
Evocalcet, similar to cinacalcet, lowers the PTH-calcium setpoint and inhibits parathyroid cell proliferation in a mouse model of primary hyperparathyroidism. These findings suggest that evocalcet may not only reduce PTH secretion but also attenuate disease progression in hyperparathyroidism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Medicine, Vascular Science Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. imanishig@gmail.com.
- Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. imanishig@gmail.com.
- Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Biomedical Science Research Laboratories 1, Research Unit, R&D Division, Kyowa Kirin Co., Ltd, Shizuoka, Japan.
- Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan.
- Department of Research Support Platform, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Imanishi, Y., Hirakawa, T., Haruyama, W., Tsushida, K., Sakai, M., Kitayama, T., Kawata, T., Donoue, E., Inoue, K., Kobayashi, I., Nagata, Y., Kurajoh, M., Shoji, T., Arnold, A., & Emoto, M. (2026). Evocalcet improved the PTH–calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-026-01699-y
Vancouver
Imanishi Y, Hirakawa T, Haruyama W, Tsushida K, Sakai M, Kitayama T, et al. Evocalcet improved the PTH–calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism. Journal of Bone and Mineral Metabolism. 2026. doi:10.1007/s00774-026-01699-y
BibTeX
@article{Imanishi2026,
author = {Imanishi, Yasuo and Hirakawa, Tomoe and Haruyama, Waka and Tsushida, Keigo and Sakai, Mariko and Kitayama, Tetsuya and Kawata, Takehisa and Donoue, Emi and Inoue, Keisuke and Kobayashi, Ikue and Nagata, Yuki and Kurajoh, Masafumi and Shoji, Tetsuo and Arnold, Andrew and Emoto, Masanori},
title = {Evocalcet improved the PTH–calcium setpoint and suppressed parathyroid proliferation in mice model of primary hyperparathyroidism},
journal = {Journal of Bone and Mineral Metabolism},
year = {2026},
doi = {10.1007/s00774-026-01699-y}
}
EUVIMED